Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels
β Scribed by Widmer, N; Rumpold, H; Untergasser, G; Fayet, A; Buclin, T; Decosterd, L A
- Book ID
- 110057187
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 104 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) are upregulated in vascular endothelial and smooth muscle cells by cytokines produced at sites of inflammation. The cytokine profile for induction of VCAM-1, however, is different for the two cell types. Tumor
## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatinβbased chemotherapy, mostly in combination with 5βFU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes